Medical Adjudication & Blinding Governance

Why this matters

Endpoint adjudication gives sponsors and regulators confidence that outcomes (e.g., myocardial infarction, stroke, disease progression) were identified consistently and without bias. That only works if:

• Clinicians who adjudicate events are independent of the trial team’s day‑to‑day work, and
• Everyone outside a small unblinded group remains blind to treatment (which arm a participant received).

Poor role design, unsafe queries, or mixing randomization data into operational views can unintentionally unblind teams and jeopardize the credibility of results. This page shows how to structure your datasets, roles, and workflows so adjudication runs smoothly while blinding stays intact.

Core concepts & definitions

Adjudication committee (AC) A panel of independent clinicians, blinded to treatment, who confirm whether suspected events meet the protocol‑defined endpoint criteria. Also called a clinical events committee (CEC); not the data monitoring committee (DMC), which may see unblinded interim data. They follow a written adjudication charter.

Adjudication charter The playbook for the AC: membership and conflicts of interest, event definitions, required evidence, decision rules (e.g., 2‑of‑3 agreement), timelines, and documentation.

Event packet A de‑identified bundle prepared for the AC (e.g., key EKG/ECG strips, lab values, imaging reports, narrative timeline). It must not reveal treatment or randomization details.

Adjudication eCRF/module A controlled form where AC members record outcomes, rationale, and timestamps. Access is restricted; outputs feed analysis datasets.

Blinding Keeping treatment assignments hidden (also called masking) from participants, investigators, and trial personnel. In this context, the data manager (DM), monitors, and site staff remain blinded; only a minimal, predefined unblinded group (e.g., independent sponsor statistician, drug supply, a pharmacist where needed) can see the randomization schedule. Allocation concealment is different: it keeps the next assignment unpredictable before randomization.

Randomization schedule & IRT The randomization schedule maps subjects to treatment arms. It is generated by an independent sponsor biostatistician outside the project team and stored with strict access controls. The IRT (interactive response technology; also called IWRS or IXRS) system operationalizes randomization and drug dispensing—access to treatment data in IRT is restricted to the unblinded group.

Emergency code‑break A documented process to reveal a participant’s treatment only when medically necessary (e.g., to guide urgent care). The investigator decides and can break the code at once, without waiting for sponsor approval; every break has an audit trail and a post‑event review. Separately, pharmacovigilance (PV) may unblind a single case for expedited reporting and keeps the result from the study team.

Minimum adjudication dataset (blinding‑safe) A subject‑level dataset with: Subject ID, Event ID, event dates, key measurements, site narrative (redacted), adjudicator decision, decision date, and versioning—no treatment variables, kit numbers, or randomization numbers. It keeps the Subject ID; the treatment codes are held where blinded roles cannot reach them.

Who sees what (least‑privilege)

Workflow, step‑by‑step

1. Create the randomization schedule (independent, unblinded). An independent sponsor biostatistician generates the schedule with a validated, documented program (seed and block size kept with the unblinded records), stores it in a controlled repository, and transfers it securely to the IRT vendor. Block sizes are not disclosed to sites or the blinded team; the blinded team tests IRT and EDC with a dummy schedule. Only the unblinded group has access.

2. Design the adjudication charter and forms. Define event criteria, evidence checklists, decision rules, timelines, quorum, tie‑breakers, and documentation. Build the adjudication eCRF/module accordingly.

3. Define the adjudication dataset. Include only what the AC needs: event dates, lab/imaging values, narratives, and a unique adjudication Event ID. Exclude treatment fields, kit numbers, and randomization numbers; the treatment codes stay restricted and are joined to the study team’s data by Subject ID only after database lock and authorized unblinding.

4. Train and gate access. Grant access only after documented training, through personal accounts with role profiles: blinded DM/CRA, adjudicator, and unblinded statistician/pharmacy. Test that EDC and IRT profiles enforce least‑privilege access.

5. Capture suspected events at site. Suspected events come from site reports and pre‑specified triggers (e.g., coded adverse event terms, troponin results), run on blinded data and applied the same way to every participant. Sites remove personal identifiers and submit source materials. A blinded coordinator prepares the event packet and performs a redaction/QC check to remove treatment hints (e.g., “Arm A”, “placebo”, kit numbers).

6. Route packets to the AC. Adjudicators receive de‑identified packets, review independently, and record outcomes in the adjudication module. Disagreements follow the charter’s resolution path.

7. Record outcomes and version. The module stores decision, rationale, adjudicator ID (coded in outputs, tied to a personal account), timestamps, and version. The adjudicated outcome sits beside the site‑reported event and never overwrites it. Any changes require reason‑for‑change and audit trail.

8. Run blinding‑safe queries. DMs raise content/clarification queries to sites without implying treatment. Medical disagreements stay within the AC; avoid “clinical judgment” queries to sites. Adjudicators needing more evidence ask the coordinator, never the site directly.

9. Integrate outcomes for analysis (still blinded). Adjudication outcomes merge into the blinded EDC export for routine data review. Before database lock, every event sent for adjudication has a final decision. Treatment codes are released only after lock, through a documented unblinding; any earlier unblinded analysis (e.g., for the DMC) is done by an independent statistician.

10. Emergency code‑break (exception). If urgent care needs the treatment assignment: the investigator follows the standard operating procedure (SOP), breaks the code in IRT for that participant only, records the reason, time, and personnel, and notifies the sponsor promptly. A post‑event review follows, with corrective and preventive action (CAPA) only if the break was unjustified or spread.

What good looks like

• Role segregation is real, not nominal. Only predefined roles (e.g., the independent sponsor statistician, drug supply, and an unblinded pharmacist where needed) can see treatment. DMs, CRAs, and adjudicators operate with no exposure to the schedule.
• Blinding‑safe design. EDC listings, exports, and dashboards omit IRT or treatment fields. Data that could reveal treatment (e.g., drug concentrations) stay with the vendor or are masked until unblinding. Packet templates include a redaction checklist.
• Crystal‑clear charter. Definitions, evidence checklists, quorum rules, and timelines are unambiguous; disagreements have a predefined resolution path.
• Auditability. Every adjudication decision and any code‑break has timestamps, user IDs, reason‑for‑change, and an audit trail.
• Operational visibility without leakage. Status dashboards show counts and cycle times (e.g., “packets pending review”) but never show arm‑level metrics.
• Drills and negative tests. Teams rehearse code‑break procedures and actively test for potential treatment leakage (e.g., searching packets for “placebo”, kit numbers).

Worked examples

Example 1 — Cardiovascular trial (suspected myocardial infarction)

Context (self‑contained): A subject reports chest pain. The site collects ECGs, cardiac enzymes, and a clinical narrative. The AC must confirm whether this meets the myocardial infarction (MI) endpoint per charter.

Build the packet:

• Must include: symptom onset date/time, troponin values with collection dates, ECG summaries, hospital discharge summary, relevant imaging/report excerpts, and a site narrative timeline.
• Must not include: treatment arm, drug kit numbers, IRT screenshots, or progress notes that mention “placebo” or “active”.

Adjudication data fields:

• Subject ID, Event ID, event start/stop dates, key measurements, AC decision (e.g., “Definite MI / Probable MI / Not MI”), decision date, adjudicator ID (coded), rationale (short text).

Blinding‑safe query example:

• Unsafe: “Given the subject is on active drug, can you explain the troponin rise?”
• Safe: “Please confirm the highest troponin value and corresponding collection date for the 24‑hour window after symptom onset.”

Outcome integration:

• Decision “Definite MI” is stored in the adjudication module and appears in the blinded EDC export. No treatment fields are added.

Example 2 — Oncology trial (progression by imaging)

Context (self‑contained): A subject’s CT scan suggests tumor growth. The endpoint is progression per rules in the charter modeled on RECIST (Response Evaluation Criteria in Solid Tumors).

Build the packet:

• Include: target lesion measurements by date, radiologist report excerpts, imaging dates, and site narrative of symptoms.
• Exclude: scan headers with “Arm A/B” overlays, dosing logs, or infusion notes that could reveal treatment.

Adjudication flow:

• Two adjudicators independently assess progression. If disagreement, a third adjudicator breaks the tie per charter.

Blinding‑safe query example:

• Unsafe: “Was progression expected in the placebo group at this visit?”
• Safe: “Please confirm the scan date and upload the radiology report for the non‑target lesions assessed at this visit.” Whether the change meets the charter’s progression criteria is for the adjudicators, not the site.

Outcome integration:

• Store decision (“Progression”/“No progression”), supporting dates, and reason codes in the adjudication eCRF. The DM remains blinded throughout.

Example 3 — Emergency code‑break (serious safety event)

Context (self‑contained): A subject experiences a life‑threatening event. Treating physicians request treatment assignment to guide care.

Immediate steps:

1. The investigator decides that knowing the treatment will change care and triggers the emergency code‑break per SOP.
2. No sponsor approval is needed first; contacting the medical monitor must not delay the break.
3. The investigator performs the code‑break in IRT for that subject only.
4. The system logs who accessed what, when, and why; the subject’s care proceeds.
5. The investigator documents the break and notifies the sponsor that it happened, without passing the assignment to blinded staff; a review confirms it was justified and contained (no broader unblinding). The site reports the event to PV as a serious adverse event (SAE) as usual.

Important: The DM and AC remain blinded; the assignment never goes into the EDC, a query, or a packet. Anyone who learns an assignment by accident does not pass it on and reports the unblinding (not the assignment) per SOP for documentation and impact assessment.

Pitfalls & misconceptions

• Misconception: The project biostatistician should generate the randomization schedule. Reality: Use an independent sponsor biostatistician outside the project team to preserve blinding.

• Anti‑pattern: Event packets or listings include treatment identifiers, kit numbers, or IRT screenshots. Fix: Redact and QC with a checklist before release.

• Leakage via joins: Combining adjudication data with a data mart that silently includes treatment fields. Fix: Maintain separate schemas and validate extracts for the absence of treatment columns.

• Unsafe queries: Queries that imply or guess treatment (“since they’re likely on placebo…”). Fix: Focus on facts, dates, measurements, and definitions. Never speculate on treatment in site communications.

• Too‑broad access: Many users can see the randomization list “for convenience.” Fix: Enforce least‑privilege; audit access routinely.

• Unstructured narratives: Free‑text notes copy/paste “Arm A” or dosing details into packets. Fix: Provide packet templates and redaction training.

Practice in the wild (checklist)

• Publish a clear adjudication charter (criteria, evidence, timelines, disagreement handling).
• Create packet templates and a redaction checklist; train sites and coordinators.
• Build an adjudication module/eCRF with required fields, versioning, and audit trail.
• Define a blinding‑safe adjudication dataset (no treatment fields, unique Event ID).
• Lock down the randomization schedule and IRT treatment data to the unblinded group.
• Configure EDC/exports/dashboards to exclude treatment data for blinded roles.
• Maintain a query library with safe wording; prohibit speculation about treatment.
• Test the emergency code‑break function in the IRT test environment (no real codes broken); review every real break afterwards.
• Monitor for leakage (automated keyword scans for “placebo”, kit numbers, arm labels).
• Review access logs periodically; remove unnecessary privileges.

Key points to remember

• Keep adjudication independent and all operational roles blinded; apply strict least‑privilege access at every step.
• The randomization schedule is created and controlled by an independent sponsor biostatistician outside the project team; in IRT/IWRS, only the unblinded group can see treatment assignments (sites and blinded staff use its blinded functions).
• Maintain data segregation: adjudication datasets include only subject/event identifiers, dates, key measurements, decisions, and timestamps—no treatment fields, kit numbers, or randomization numbers; for the study team, treatment codes are joined only after database lock and authorized unblinding.
• Event packets are de‑identified and redacted to remove treatment hints (arm labels, kit numbers, dosing notes, IRT screenshots); use a standard template and a redaction checklist with QC.
• The adjudication charter governs definitions, evidence requirements, decision rules, timelines, and disagreement handling; clinical disagreements are resolved within the adjudication committee, not via site queries.
• Use a controlled adjudication eCRF/module with versioning, reason‑for‑change, timestamps, adjudicator IDs (coded in outputs, tied to personal accounts), and a full audit trail.
• Write blinding‑safe queries that ask for factual clarifications (dates, values, documents) and never reference or imply treatment or arm‑level expectations.
• Provide operational visibility without leakage: dashboards show packet counts, cycle times, and statuses—never arm‑level metrics.
• Emergency code‑breaks are exceptional and strictly for immediate medical need: the investigator follows the SOP and performs a subject‑level break in IRT without waiting for sponsor approval, logs who/why/when, and notifies the sponsor; every break is reviewed (CAPA only if unjustified); the broader team remains blinded.
• Continuously monitor and enforce controls: rehearse code‑breaks, scan packets/listings for leakage keywords, review access logs, and remove unnecessary privileges.
• Integrate adjudication outcomes into blinded exports for routine monitoring; any unblinded analyses are conducted only by the independent statistician when permitted.
• Document everything—from packet QC to adjudication decisions and access changes—to preserve auditability and protect the credibility of results.